EUVIMEDEUVIMED entdecken
Crossref

Chronic high-altitude hypoxia exacerbates cognitive impairment and Alzheimer’s disease pathology

Jie-Ming Jian, Xin-Peng Li, Jun-Hao Xie, Jian-Ni Hu, Jun Liang, Li Zhu, Hong-Da Zhao, Fan Zeng, Wang-Sheng Jin, Dong-Yu Fan iD, Hao-Lun Sun iD

Journal of Alzheimer’s Disease · 2026-05 · 111 (1) · 422-432

DOI: 10.1177/13872877261431844 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Alzheimer’s Disease, online erschienen am 20.03.2026. Verfasst von Jie-Ming Jian und 10 weiteren Autor:innen. Beteiligte Einrichtung: 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China, Kunming, Yunnan, China. Hauptthemen laut MEDLINE: Alzheimer Disease, Hypoxia, Altitude, Cognitive Dysfunction. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Natural Science Foundation of Chongqing, China, Natural Science Foundation of Shigatse, China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Chronic hypoxia has been acknowledged as a significant risk factor for Alzheimer's disease (AD), yet the impact of high-altitude hypoxia on AD pathogenesis remains poorly understood.

Objective

This study aims to investigate the effects of chronic high-altitude hypoxia on cognitive function and AD-related pathology.

Methods

A cross-sectional cohort comprising 186 high-altitude migrants (HAM) and 378 high-altitude natives (HAN) was recruited for a preliminary assessment. We further conducted 101 HAM, 135 HAN, and 66 low-altitude controls (LA) for plasma biomarkers research. Plasma Aβ 40 , Aβ 42 , and T-tau levels were quantified by SIMOA. In parallel, APP/PS1 mice were exposed to hypobaric hypoxia (simulated at 5,500 m) or normoxia for 30 days, followed by behavioral tests, brain immunohistochemistry, and transcriptomic/proteomic analyses.

Results

HAM subjects exhibited significant deficits in Montreal Cognitive Assessment scores and delayed recall subscores compared to LA controls, with both measures showing a positive correlation with peripheral oxygen saturation (SpO₂). Notably, HAN showed preserved memory despite lower overall cognitive scores. Plasma levels of amyloid-β (Aβ) 40 , Aβ 42 , and Aβ 42 /Aβ 40 ratio were significantly lower in both HAM and HAN groups compared to the LA group. In mice, chronic hypoxia exacerbated hippocampal Aβ deposition and induced spatial memory decline. Multi-omics analyses revealed the upregulation of oxidative stress and neuroinflammatory pathways and identified S100A8/A9 as a potential key mediator in hypoxia-accelerated AD pathology.

Conclusions

Our findings demonstrate that chronic high-altitude hypoxia contributes to cognitive decline and AD-related pathological changes, likely mediated by Aβ burden and oxidative stress. High-altitude hypoxia might be an important environmental risk factor for AD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseHypoxiaAltitudeCognitive DysfunctionAltitude SicknessAnimalsMaleHumansFemaleAmyloid beta-PeptidesMice, TransgenicCross-Sectional StudiesMiceAgedAmyloid beta-Protein PrecursorDisease Models, Animaltau ProteinsBrainPeptide FragmentsCohort Studies

Stichwörter der Autor:innen

Alzheimer's diseaseamyloid-βcognitive impairmenthigh altitudehypoxia

Substanzen

Amyloid beta-PeptidesAmyloid beta-Protein Precursortau ProteinsPeptide Fragmentsamyloid beta-protein (1-42)

Autor:innen und Institutionen

  • 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China, Kunming, Yunnan, China.
  • Department of Neurology and Centre for Clinical Neuroscience, Daping Hospital, Army Medical University, Chongqing, China.
  • Chongqing Key Laboratory of Ageing and Brain Diseases, Chongqing, China.
  • Institute of Brain and Intelligence, Army Medical University, Chongqing, China.
  • Department of Special Medicine, Daping Hospital, Army Medical University, Chongqing, China.
  • Shigatse Branch, Xinqiao Hospital, Army Medical University, Shigatse, China.

ORCID-Profile: Dong-Yu Fan, Hao-Lun Sun

Förderung

  • National Natural Science Foundation of China
  • National Natural Science Foundation of Chongqing, China
  • Natural Science Foundation of Shigatse, China

Zitieren

APA

Jian, J. M., Li, X. P., Xie, J. H., Hu, J. N., Liang, J., Zhu, L., Zhao, H. D., Zeng, F., Jin, W. S., Fan, D. Y., & Sun, H. L. (2026). Chronic high-altitude hypoxia exacerbates cognitive impairment and Alzheimer’s disease pathology. Journal of Alzheimer’s Disease, 111(1), 422-432. https://doi.org/10.1177/13872877261431844

Vancouver

Jian JM, Li XP, Xie JH, Hu JN, Liang J, Zhu L, et al. Chronic high-altitude hypoxia exacerbates cognitive impairment and Alzheimer’s disease pathology. Journal of Alzheimer’s Disease. 2026;111(1):422-432. doi:10.1177/13872877261431844

BibTeX
@article{Jian2026,
  author = {Jian, Jie-Ming and Li, Xin-Peng and Xie, Jun-Hao and Hu, Jian-Ni and Liang, Jun and Zhu, Li and Zhao, Hong-Da and Zeng, Fan and Jin, Wang-Sheng and Fan, Dong-Yu and Sun, Hao-Lun},
  title = {Chronic high-altitude hypoxia exacerbates cognitive impairment and Alzheimer’s disease pathology},
  journal = {Journal of Alzheimer’s Disease},
  year = {2026},
  volume = {111},
  number = {1},
  pages = {422--432},
  doi = {10.1177/13872877261431844}
}
Kostenlos starten →